Загрузка...
Immunotherapy After Immunotherapy: Response Rescue in a Microsatellite Instability-High Colorectal Cancer Patient Post-Pembrolizumab
BACKGROUND: Metastatic microsatellite instability-high (MSI-H) colorectal cancer (CRC) is one of the rare gastrointestinal tumors where immune checkpoint inhibitors (ICIs) have a defined therapeutic role. Single-agent nivolumab, single-agent pembrolizumab and the combination of nivolumab plus ipilim...
Сохранить в:
| Опубликовано в: : | Clin Colorectal Cancer |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261248/ https://ncbi.nlm.nih.gov/pubmed/32146081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2020.02.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|